Keywords: PON1، پاراکسوناز 1; CBS, cystathionine beta synthase; GSH, glutathione; Hcy, homocysteine; HHcy, hyperhomocysteinemia; HO-1, heme oxygenase I; PON1, paraoxonase 1; NQO1, NAD(P)H:quinone oxidoreductase; XME, xenobiotic-metabolizing enzymeHyperhomocysteinemia; Mice; Liver; Cad
مقالات ISI PON1، پاراکسوناز 1 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: PON1، پاراکسوناز 1; CVD, cardiovascular disease; CA, cold-adapted; CON, control group; CAT, catalase; GPX1, glutathione peroxidase 1; GR, glutathione reductase; GSH, reduced glutathione; CD, conjugated dienes; PON1, paraoxonase 1; CEC, cholesterol efflux; LDL-C, low-density
Contrasting genetic influence of PON 1 coding gene polymorphisms L55M and Q192R on individuals’ response to environmental agents
Keywords: PON1، پاراکسوناز 1; PON1, paraoxonase 1; OP, organophosphate; AChE, acetylcholinesterase; PO, paraoxon; CPO, chlorpyrifos oxon; DZO, diazoxonParaoxonase; L55M; Q192R; Organophosphate; Poisoning grade
Paraoxonase 1 and cytochrome P450 polymorphisms in susceptibility to acute organophosphorus poisoning in Egyptians
Keywords: PON1، پاراکسوناز 1; OP, organophosphorus; PON1, paraoxonase 1; CYP, cytochrome P450 monooxygenases; PChE, pseudo-cholinesterase; SNPs, single nucleotide polymorphisms; PCR-RFLP, polymerase chain reaction-restriction fragment length polymorphismParaoxonase 1; CYP2D6; Acute or
Effect of calcium channel blockers on paraoxonase-1 (PON1) activity and oxidative stress
Keywords: PON1، پاراکسوناز 1; HDL, high-density lipoprotein; LDL, low-density lipoprotein; Mw, molecular weight; PON1, paraoxonase 1; SDS-PAGE, sodium dodecyl sulfate polyacrylamide gel electrophoresisParaoxonase; Nifedipine; Nitrendipine; Isradipine; Amlodipine besylate
Functional paraoxonase 1 variants modify the risk of Parkinson's disease due to organophosphate exposure
Keywords: PON1، پاراکسوناز 1; PD, Parkinson's disease; OPs, organophosphorus pesticides; PON1, paraoxonase 1; SNPs, single nucleotide polymorphisms; HIPAA, Health Insurance Portability and Accountability Act; GIS, geographic information system; UCLA, University of California at Los An
Pomegranate and type 2 diabetes
Keywords: PON1، پاراکسوناز 1; NF-κB, nuclear factor κB; ROS, reactive oxygen species; PFE, pomegranate flower extract; PPAR, peroxisome proliferator-activated receptor; LPO, lipid peroxidation; PON1, paraoxonase 1; TGs, triglycerides; ZDF rats, Zucker fatty diabetic rats; STZ rats, st
Paraoxonase 1 polymorphisms L55M and Q192R were not risk factors for Parkinson's disease: A HuGE review and meta-analysis
Keywords: PON1، پاراکسوناز 1; PON1, Paraoxonase 1; PD, Parkinson’s disease; HuGE, human genome epidemiology; OR, odds ratio; ORs, odds ratios; CIs, confidence intervals; s.e. of logOR, standard error of the logOR; logOR, natural logarithm of the OR; PCR, polymerase chain reaction; RFL
Genetic variants in antioxidant genes are associated with sperm DNA damage and risk of male infertility in a Chinese population
Keywords: PON1، پاراکسوناز 1; ROS, reactive oxygen species; GPX1, glutathione peroxidase 1; CAT, catalase; PON1, paraoxonase 1; SOD2, superoxide dismutase 2; NQO1, NAD(P)H dehydrogenase quinone 1; SNP, single-nucleotide polymorphism; 8-OHdG, 8-hydroxydeoxyguanosineOxidative stress; An
Low serum PON1 activity: An independent risk factor for coronary artery disease in North–West Indian type 2 diabetics
Keywords: PON1، پاراکسوناز 1; PON1, paraoxonase 1; ASO-PCR, allele specific oligonucleotide-PCR; BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; LD, linkage disequilibrium; SNPs, single nucleotide polymorphisms; T-CHO, tot
Crossroads in the evaluation of paraoxonase 1 for protection against nerve agent and organophosphate toxicity
Keywords: PON1، پاراکسوناز 1; PON1, paraoxonase 1; HDL, high density lipoprotein; OP, organophosphate; CWNA, chemical warfare nerve agent; DFP, diisopropylfluorophosphate; CPO, chloropyrifos oxon; AChE, acetylcholinesterase; ACh, acetylcholine; BChE, butyrylcholinesterase; Sarin, 2-(f
Systematic review of biomonitoring studies to determine the association between exposure to organophosphorus and pyrethroid insecticides and human health outcomes
Keywords: PON1، پاراکسوناز 1; OP, organophosphates; PYR, pyrethroids; AChE, acetylcholinesterase; PON1, paraoxonase 1; CHAMACOS, Center for the Health Assessment of Mothers and Children of Salinas; CCCEH, Columbia Center for Children's Environmental Health; DMP, dimethylphosphate; DMT
Polymorphisms of pon1 and pon2 genes in hemodialyzed patients
Keywords: PON1، پاراکسوناز 1; HDL, high-density lipoproteins; LDL, low-density lipoproteins; PON1, paraoxonase 1; PON2, paraoxonase 2; PCR, polymerase chain reaction; RFLP, restriction fragment length polymorphism; VLDL, very low-density lipoproteinsHemodialysis; Paraoxonase 1; Paraox
Recombinant paraoxonase 1 protects against sarin and soman toxicity following microinstillation inhalation exposure in guinea pigs
Keywords: PON1، پاراکسوناز 1; PON1, paraoxonase 1; HDL, high density lipoprotein; rePON1, recombinant PON1; OP, organophosphate; CWNA, chemical warfare nerve agent; AChE, acetylcholinesterase; BChE, butyrylcholinesterase; p-NPA, p-nitrophenylacetate; BCA, bicinchoninic acid; Sarin, 2-
In vitro efficacy of paraoxonase 1 from multiple sources against various organophosphates
Keywords: PON1، پاراکسوناز 1; PON1, paraoxonase 1; OPs, organophosphates; CWNAs, chemical warfare nerve agents; DFP, diisopropylfluorophosphate; DEP, diethyl paraoxon; DMP, dimethyl paraoxon; HPON1, human PON1; RPON1, rabbit PON1; rePON1, recombinant PON1; Apo AI, apolipoprotein AI; A
Interaction of Folate Intake and the Paraoxonase Q192R Polymorphism with Risk of Incident Coronary Heart Disease and Ischemic Stroke: The Atherosclerosis Risk in Communities Study
Keywords: PON1، پاراکسوناز 1; Coronary Heart Disease; Folate; Genetic Polymorphism; Incidence; StrokeCHD, coronary heart disease; Hcy, homocysteine; CI, confidence interval; PON1, paraoxonase 1; HDL, high-density lipoprotein; OR, odds ratio; ARIC, Atherosclerosis Risk in Communities;
Effect of non-genetic factors on paraoxonase 1 activity in patients undergoing hemodialysis
Keywords: PON1، پاراکسوناز 1; PON1, paraoxonase 1; HDL, high density lipoprotein; LDL, low density lipoprotein; apoAI, apolipoproteine AI; apoB, apolipoproteine B; MDA, malondialdehyde; PBS, phosphate buffer saline; POX, PON1 paraoxonase activity; ARE, PON1 arylesterase activity; POX/
Human PON1, a biomarker of risk of disease and exposure
Keywords: PON1، پاراکسوناز 1; CPF, chlorpyrifos; CPO, chlorpyrifos oxon; DZ, diazinon; DZO, diazoxon; PO, paraoxon; PD, Parkinson disease; PON1, paraoxonase 1; PON2, paraoxonase 2; PON3, paraoxonase 3; PCR, polymerase chain reaction; tgHuPON1R192, transgenic human PON1R192; tgHuPON1Q1
Comparative proteomic profiling of plasma very-low-density and low-density lipoproteins
Keywords: PON1، پاراکسوناز 1; Apo, apolipoprotein; HDL, high-density lipoprotein; iTRAQ, isobaric tag for relative and absolute quantitation; 2-DE, two-dimensional gel electrophoresis; ALB, albumin; SCX, strong cation exchange; PON1, paraoxonase 1; A1AT, α1-antitrypsin; PCYOX1, prenyl
Oxidative inactivation of lactonase activity of purified human paraoxonase 1 (PON1)
Keywords: PON1، پاراکسوناز 1; PON1, paraoxonase 1; HDL, high density lipoprotein; LDL, low density lipoprotein; DOPC, dioleoyl phosphatidylcholineLactonase; Arylesterase; Paraoxonase; Oxidative inactivation; Reactive oxygen specie; Antioxidant
Validation of PON1 enzyme activity assays for longitudinal studies
Keywords: PON1، پاراکسوناز 1; PON1, Paraoxonase 1; HDL, high-density-lipoprotein; OP, organophosphate; IBD, inflammatory bowel disease; CHAMACOS, Center for Health Assessment of Mothers and Children of Salinas; UCB, University of California, Berkeley; UW, University of Washington, Sea
Human carotid atherosclerotic plaque increases oxidative state of macrophages and low-density lipoproteins, whereas paraoxonase 1 (PON1) decreases such atherogenic effects
Keywords: PON1، پاراکسوناز 1; Ox-LDL, oxidized low-density lipoproteins; PON1, paraoxonase 1; HDL, high-density lipoprotein; LE, lesion extract; EtAc, ethyl acetate; OS, oxidative stress; 7-OOH, 7-hydroperoxycholesterols; 7-OH, 7-hydroxycholesterols; 7-Keto, 7-ketocholesterol; CVD, ca
Brazil nut ingestion increased plasma selenium but had minimal effects on lipids, apolipoproteins, and high-density lipoprotein function in human subjects
Keywords: PON1، پاراکسوناز 1; Humans; Cholesterol; Dietary selenium; Lipoproteins; Nanoparticles; EmulsionsApo A-I, apolipoprotein A-I; Apo B, apolipoprotein B; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MUFA, monounsaturated fatty acids; PON1, paraoxonase 1; PUFA, p
Polymorphisms in metabolic GSTP1 and DNA-repair XRCC1 genes with an increased risk of DNA damage in pesticide-exposed fruit growers
Keywords: PON1، پاراکسوناز 1; GSTP1, glutathione S-transferase P1; PON1, paraoxonase 1; PON2, paraoxonase 2; GSTM1, glutathione S-transferase M1; GSTT1, glutathione S-transferase T1; CYP3A5, cytochrome P450 3A5; BER, base excision repair; XRCC1, X-ray cross-complementing group 1; NER,
Oxidized to non-oxidized lipoprotein ratios are associated with arteriosclerosis and the metabolic syndrome in diabetic patients
Keywords: PON1، پاراکسوناز 1; Lipid peroxidation; Atherosclerosis; Metabolic syndrome; Paraoxonase 1; Polymorphism; Type 2 diabetesT2DM, Type 2 diabetes mellitus; PON1, paraoxonase 1; OxLDL, oxidized low density lipoprotein; OxLDL-Ab, autoantibodies against OxLDL; CVD, cardiovascular